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Abstract
Both thyrotropin-releasing hormone (TRH) and RO 15-4513 antagonize ethanol-induced depression,
but this common property does not infer that both compounds share similar mechanisms of action.
In the present studies, both TRH (30 mg/kg, i.p.) and RO 15-4513 (10 mg/kg, i.p.) reversed ethanol-
induced depression of locomotor activity, in accord with previous reports. However, the
benzodiazepine antagonist, RO 15-1788, blocked this action of RO 15-4513, while exerting no effect
on the analeptic action of TRH. Using a model of seizure activity electrically elicited from the inferior
colliculus, ethanol exerted a dose-related attenuation of seizure activity. This anticonvulsant action
of ethanol was not altered by TRH (30 mg/kg, i.p.), but RO 15-4513 (3 mg/kg) reversed the effect
of the 0.5, but not the 1.0 g/kg, dose of ethanol. In addition, pretreatment with RO 15-4513 (1 or 3
mg/kg, i.p.), but not TRH (30 mg/kg, i.p.), caused seizure generalization into the forebrain following
inferior collicular stimulation, further verifying the proconvulsant properties of RO 15-4513. In
conclusion, the analeptic action of TRH appears independent of benzodiazepine activity, and in
contrast to RO 15-4513, TRH does not exhibit proconvulsant properties. Furthermore, because TRH
did not antagonize both depressant actions of ethanol studied, it appears unlikely that TRH directly
interacts with the molecular basis of ethanol action.
Several chemically dissimilar compounds have been found to antagonize the sedative actions
of ethanol, such as bicuculline, picrotoxin, pentylenetetrazol and most recently RO
15-4513.1–3 A property common to most of these compounds is the ability to influence the
function of the γ-aminobutyric acid-benzodiazepine-chloride channel complex.4 Another
compound that can reverse the depressant actions of ethanol is thyrotropin-releasing hormone
(TRH).5–8 Although several investigators have reported that benzodiazepines displace in vitro
TRH binding,9, 10 the biological relationship of this interaction to the analeptic action of TRH
has not been delineated.
Another commonality among many ethanol antagonists is their proconvulsant property.
Similarly, withdrawal from chronic ethanol treatment induces a proconvulsant state, where
audiogenic seizures can be elicited. These audiogenic seizures depend upon function within
the inferior colliculus.11 An identical convulsive progression can be elicited by chronic
electrical stimulation of the inferior collicular cortex,12 and this inferior colliculus stimulation
model allows quantification of both anti- and proconvulsant activity. However, there have been
no reports of a proconvulsant action of TRH.
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In the present investigations, we have utilized ethanol-induced depression of locomotor activity
and an ethanol sensitive seizure model to evaluate TRH and RO 15-4513 interactions with
ethanol. By combining the locomotor and seizure measures of ethanol action, both functional
and mechanistic properties of TRH and RO 15-4513 could be compared.
MATERIALS AND METHODS
Animals
All of the animals were viral-free, male Sprague-Dawley rats weighing between 350 and 400
g. The animals were maintained under a 12-hr light-dark cycle (7:00 a.m. to 7:00 p.m. light)
and provided free access to water and food.
Locomotor Activity Measures
Locomotor activity was quantified using eight doughnut-shaped activity monitors housed in
sound-attenuated, fan-ventilated chambers each illuminated with a 7-w lamp.13 Six photocells
were evenly spaced about a circular runway (9 cm inside; 30 cm outside diameter, 20 cm deep);
each interruption of the photocell beam was recorded as an activity count. Counts were
accumulated every 10 min over a 1.5-hr period.
Electrode Implantation and Seizure Testing
The animals were anesthetized with 40 mg/kg pentobarbital and placed into a stereotaxic frame.
Then, a bipolar electrode (insulated 0.008-inch stainless steel wire) was implanted into the
inferior collicular cortex (0.28 mm IAL, 1.7 mm L, 3.6 mm V) according to the atlas of Paxinos
and Watson.14 The implant was secured with cranioplastic cement to four screws placed in the
skull, and the animals were allowed at least 7 days to recover from the surgery.
After the recovery period, the animals received electrical stimulation of the inferior collicular
cortex (30 Hz, 1.5 msec duration, monophasic square waves) using a current titration method
as previously described.12 This allowed determination of the minimum current intensity
necessary to produce poststimulus wild running and measurement of the wild running duration
for each animal. A stable threshold current for seizure initiation then was determined over three
to four trials. Subsequently, if the animals were stimulated twice a day, the wild running
duration increased until on a given test, the wild running seizure was followed by the
appearance of forelimb tonic extension and hindlimb clonus, indicants that seizure activity had
generalized from the inferior collicular cortex into the forebrain.12 This seizure generalization
demarcates an increase in seizure severity. Thus, prior to electrically induced seizure spread,
the appearance of generalized seizure behaviors after a drug treatment establishes a
proconvulsant action for the drug. Anticonvulsant effects can be measured at any point in the
testing procedure, using changes in seizure threshold current or attenuation of seizure
generalization.
Drug Testing
For the locomotor studies, all animals were treated first with 2.0 g/kg ethanol i.p. and 1 min
later received either TRH (30 mg/kg, i.p.) or RO 15-4513 (10 mg/kg, i.p.). Previous
investigations have shown that these doses of TRH or RO 15-4513 effectively reverse ethanol-
induced sedation.2, 5 In studies using RO 15-1788, this compound was administered 1-min
postethanol, while the TRH or RO 15-4513 was administered 2-min postethanol. Control
groups included saline, TRH, or RO 15-4513 alone.
In order to evaluate the anticonvulsant activity of ethanol in the inferior collicular seizure
model, the effects of various doses of ethanol (0.3, 0.5, and 1.0 g/kg, i.p.) were assessed 30
min after ethanol administration. The interaction between ethanol and RO 15-4513 was
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assessed by administering 3.0 mg/kg RO 15-4513 2 min prior to the administration of either
0.5 or 1.0 g/kg dose of ethanol and assessing seizure activity 30 min later. The TRH-ethanol
interaction involved initial treatment with 0.5 g/kg ethanol, then 15 min later administration
of 30 mg/kg TRH, and finally 15 min post-TRH, the seizure activity was assessed.
Proconvulsant properties of these ethanol antagonists were evaluated by administering doses
of RO 15-4513 (1.0 or 3.0 mg/kg, i.p.) 30 min prior to the seizure threshold test, or a dose of
TRH (30 mg/kg, i.p.) 15 min prior to the seizure threshold test.
Statistics
The effects of the various drug treatments in the locomotor activity tests were evaluated by a
one-way analysis of variance, followed by t tests for multiple comparisons. The incidence of
seizure generalization was evaluated by a χ2 test, while the threshold current for seizure
initiation was evaluated by a paired t test for repeated measures. A probability of p < 0.05 was
considered a significant change.
RESULTS
Effect of TRH and RO 15-4513 on Ethanol-induced Impairment of Locomotor Activity
In agreement with previous investigations,6 ethanol significantly decreased locomotor activity
and TRH reversed this depressant action of ethanol (Fig 1). Like TRH, RO 15-4513 reversed
the ethanol-induced depression of locomotor activity. The time course for this antagonism of
ethanol sedation, shown in Fig. 2, appears similar for both TRH and RO 15-4513. The
benzodiazepine antagonist, RO 15-1788, blocked this analeptic action of RO 15-4513 (Fig. 1),
in agreement with previous reports.2, 3 In contrast, RO 15-1788 did not alter the analeptic
action of TRH. Fig. 1 shows that the combination of TRH and RO 15-1788 produced more
activity than TRH alone, even though this change did not reach significance (p < 0.1). RO
15-1788 had no effect on ethanol-induced depression of locomotor by itself (ethanol alone =
546 ± 164 counts/90 min; ethanol + RO 15-1788 = 627 ± 78 counts/90 min). When compared
to saline controls (1388 ± 490 counts/90 min), RO 15-4513 (10 mg/kg, i.p.) alone did not alter
locomotor activity (1440 ± 580 counts/90 min), but TRH (30 mg/kg, i.p.) alone did significantly
elevate locomotor activity (3214 ± 476 counts/90 min).
Effect of Ethanol on Inferior Collicular Seizure Activity
The initial assessment of ethanol action on inferior collicular seizure activity used chronically
stimulated animals, such that indicants of seizure generalization (i.e., the appearance of
forelimb tonus followed by hindlimb clonus) occurred following an acute inferior collicular
stimulation. In these animals, the 0.3 g/kg dose of ethanol had no effect on seizure spread from
the inferior colliculus to the forebrain (Table 1), while the 0.5 and 1.0 g/kg doses of ethanol
completely blocked the appearance of forelimb tonus and hindlimb clonus. In addition, Table
1 shows that the 0.3 and 0.5 g/kg dose of ethanol had no effect on the threshold current for
seizure initiation, but the 1.0 g/kg dose produced a small, but significant, elevation in the seizure
threshold current.
Effects of TRH and RO 15-4513 on the Anticonvulsant Action of Ethanol
As seen in Table 2, the attenuation of seizure generalization caused by 0.5 mg/kg ethanol was
completely prevented by 3.0 mg/kg of RO 15-4513. However, this dose of RO 15-4513 had
no effect on attenuation of seizure generalization induced by the 1.0 g/kg dose of ethanol.
Conversely, TRH (30 mg/kg) had no effect on the ethanol attenuation of seizure generalization.
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Effects of RO 15-4513 and TRH on Seizure Generalization
In acutely stimulated animals, seizure generalization does not appear after the wild running
seizure. Pretreatment with various doses of RO 15-4513 caused an increasing incidence of
seizure generalization without changing the threshold current for seizure initiation (Table 3).
A high dose of TRH (30 mg/kg) had no effect on seizure generalization or on the threshold
current for seizure initiation (Table 3).
DISCUSSION
The locomotor studies verified that both TRH and RO 15-4513 can reverse ethanol-induced
sedation. As previously reported,2 the analeptic action of RO 15-4513 was shown to depend
upon an interaction with the benzodizepine receptor. However, blockade of the benzodiazepine
receptor by RO 15.1788 did not alter the analeptic action of TRH. Thus, the TRH reversal of
ethanol-induced sedation does not depend upon a benzodiazepine receptor interaction— a
finding which implies that the in vitro displacement of TRH binding by benzodiazepines9, 10
is not pertinent to the in vivo analeptic action of TRH.
Two other neurotransmitter systems, acetylcholine and γ-aminobutyric acid, have been
implicated in the actions of TRH,15, 16 but no direct link has been established between
functional measures of these neurotransmitter systems with the analeptic actions of TRH.6,
17 Therefore, unlike RO 15-4513, the neurochemical basis for the analeptic action of TRH
remains to be defined. In this regard, both the present results and previous investigations6, 8
emphasize site specificity of TRH action within the brain. As a result of this site specificity,
future mechanistic studies must focus on those brain areas pertinent to the particular functional
consequence of TRH being studied.
Using a seizure model that resembles audiogenic ethanol withdrawal seizure activity, low doses
of ethanol were found to exert anticonvulsant activity. The most prominent anticonvulsant
property of ethanol was the attenuation of seizure spread from the brainstem area into the
cortex, although the highest dose of ethanol (1.0 g/kg) significantly elevated the threshold
current for seizure initiation. This parallel to the report that ethanol administration attenuates
audiogenic seizure activity in animals withdrawn from chronic ethanol treatment17 reinforces
the probable interaction between ethanol and inferior collicular function.18
When the interaction between RO 15-4513 and ethanol anticonvulsant action was tested, the
results proved dependent upon the dose of ethanol. RO 15-4513 completely antagonized the
anticonvulsant action of the 0.5 g/kg dose of ethanol, but did not alter the anticonvulsant effects
of the 1.0 g/kg dose of ethanol. If administered alone, RO 15-4513 caused seizure
generalization from the brainstem into the forebrain. An identical facilitation of seizure
generalization also occurs following the administration of a subconvulsant dose of
pentylenetetrazol.12 This similarity reinforces the conclusion that RO 15-4513 exhibits
proconvulsant activity.20 Given the diametrically opposed action that each compound has upon
inferior collicular seizure activity, one easily could describe this interaction as an ethanol
antagonsim of the proconvulsant effects of RO 15-4513. As previously proposed by other
investigators,1, 19, 20 this dose-dependent interaction is suggestive of a mutual antagonism.
However, the present studies do not allow any conclusion regarding the molecular basis for
the RO 15-4513-ethanol interaction.
In contrast to RO 15-4513, a TRH dose three times that needed to reverse ethanol sedation7
did not affect seizure sensitivity. Furthermore, TRH administration did not alter the
anticonvulsant effects of ethanol. The dramatic TRH antagonism of high dose ethanol-induced
sedation is the antithesis of the total lack of TRH action on low dose ethanol attenuation of
seizure generalization. If TRH were directly interacting with the molecular basis of ethanol
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action on the brain, then TRH should exert some influence on both measures of ethanol action
on the brain. Therefore, TRH must antagonize ethanol-induced sedation through a mechanism
distinct from the molecular mechanism by which ethanol attenuates seizure activity.
In summary, the present findings reinforce previous conclusions that RO 15-4513 reverses
ethanol-induced depression, exhibits proconvulsant properties, and appears to function through
the γ-aminobutyric acid-benzodiazepine-chloride channel complex.1–3 In contrast to RO
15-4513, TRH neither exhibits proconvulsant properties, nor depends upon benzodiazepine
receptor function, even though the analeptic properties are as marked as those for RO 15-4513.
Clearly an analeptic mechanism exists in brain that is not linked to the benzodiazepine receptor,
and is not proconvulsant in nature.
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Effects of TRH and RO 15-4513 alone and in combination with RO 15-1788 on the depression
of locomotor activity (± SEM) induced by a 2.0 g/kg i.p. dose of ethanol (ETOH). All animals
were treated with ETOH and 1 min later received either TRH (30 mg/kg, i.p.), or RO 15-4513
(10 mg/kg, i.p). For RO 15-1788 studies, 10 mg/kg of this compound was administered, i.p.,
1-min post-ETOH, while the TRH or RO 15-4513 was administered 2-min post-ETOH. *p <
0.05 versus saline control; **p < 0.05 versus ETOH control.
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The time course of both the TRH and RO 15-4513 antagonism of ethanol sedation depicted in
Fig. 1, as compared to ETOH or saline alone. The activity counts (±SEM) were measured
within each 10-min interval.
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Table 1






Saline 0 ± 3 7/7
0.3 g/kg 0 ± 0 6/6
0.5 g/kg −4 ± 2 0/7‡
1.0 g/kg 31 ± 14‡ 0/6‡
*
Ethanol was administered i.p. 30 min prior to the test for seizure activity.
†
All animals had received chronic stimulation of the inferior collicular cortex such that a given stimulation resulted in the appearance of forelimb
tonic extension followed by hindlimb clonus, indicants of seizure generalization from the brainstem into the forebrain. The results are expressed as
number exhibiting seizure generalization/total tested.
‡
p < 0.05, versus saline controls.
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Table 2




ETOH (0.5 g/kg) + RO 15-4513
  (3 mg/kg)
5/5‡
ETOH (1 g/kg) + RO 15-4513 (3
  mg/kg)
0/6




RO 15-4513 was administered to animals 2 min prior to ethanol administration, and TRH was administered 15 min after the ethanol. All animals
were tested 30 min after the ethanol administration.
†
All animals received chronic stimulation of the inferior collicular cortex such that a given stimulation resulted in the appearance of forelimb tonic
extension followed by hindlimb clonus, indicants of seizure generalization from the brainstem into the forebrain. Results are expressed as number
exhibiting seizure generalization/total tested.
‡
p < 0.05, compared to the appropriate ETOH control.
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Table 3





TRH (30 mg/kg) 0/5
RO 15-4513
  1.0 mg/kg 3/5‡
  3.0 mg/kg 5/5‡
*
TRH was administered to animals 15 min prior to seizure testing, while RO 15-4513 was administered 30 min prior to seizure testing.
†
The animals had not received chronic stimulation of the inferior collicular cortex, so upon a given stimulation no seizure generalization would be
expected. Results are expressed as number exhibiting seizure generalization/total tested. No treatment altered the seizure threshold current.
‡
p < 0.05, compared to saline control.
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